Literature DB >> 10857099

The complement system: an overview.

B P Morgan1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10857099     DOI： 10.1385/1-59259-056-X:1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  23 in total

1.  Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.

Authors:  Malikah Abdullah; Igor Nepluev; Galyna Afonina; Sanjay Ram; Peter Rice; William Cade; Christopher Elkins
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B.

Authors:  Tamara Montes; Agustín Tortajada; B Paul Morgan; Santiago Rodríguez de Córdoba; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

3.  Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system.

Authors:  Richard Y Wang; Patricia Bare; Valeria De Giorgi; Kentaro Matsuura; Kazi Abdus Salam; Teresa Grandinetti; Cathy Schechterly; Harvey J Alter
Journal:  Hepatology       Date:  2016-10-24       Impact factor: 17.425

4.  Polyphosphate suppresses complement via the terminal pathway.

Authors:  Jovian M Wat; Jonathan H Foley; Michael J Krisinger; Linnette Mae Ocariza; Victor Lei; Gregory A Wasney; Emilie Lameignere; Natalie C Strynadka; Stephanie A Smith; James H Morrissey; Edward M Conway
Journal:  Blood       Date:  2013-12-13       Impact factor: 22.113

5.  The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice.

Authors:  B P Morgan; J Chamberlain-Banoub; J W Neal; W Song; M Mizuno; C L Harris
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

6.  Clusterin and complement activation in exfoliation glaucoma.

Authors:  Ivo Doudevski; Agueda Rostagno; Mary Cowman; Jeffrey Liebmann; Robert Ritch; Jorge Ghiso
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

7.  Cell membrane modification for rapid display of bi-functional peptides: a novel approach to reduce complement activation.

Authors:  Ledia Goga; Gustavo Perez-Abadia; Sathnur B Pushpakumar; Daniel Cramer; Jun Yan; Nathan Todnem; Gary Anderson; Chirag Soni; John Barker; Claudio Maldonado
Journal:  Open Cardiovasc Med J       Date:  2010-07-20

8.  The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro.

Authors:  Bing Ren; Jie Li; Kristopher Genschmer; Susan K Hollingshead; David E Briles
Journal:  Clin Vaccine Immunol       Date:  2012-08-01

9.  SERPING1 polymorphisms in polypoidal choroidal vasculopathy.

Authors:  Meng Li; Feng Wen; Chengguo Zuo; Xiongze Zhang; Hui Chen; Shizhou Huang; Guangwei Luo
Journal:  Mol Vis       Date:  2010-02-16       Impact factor: 2.367

10.  A humanized antibody that regulates the alternative pathway convertase: potential for therapy of renal disease associated with nephritic factors.

Authors:  Danielle Paixão-Cavalcante; Eva Torreira; Margaret A Lindorfer; Santiago Rodriguez de Cordoba; B Paul Morgan; Ronald P Taylor; Oscar Llorca; Claire L Harris
Journal:  J Immunol       Date:  2014-04-11       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.